©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Dec 28, 2014; 20(48): 18452-18457
Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18452
Published online Dec 28, 2014. doi: 10.3748/wjg.v20.i48.18452
Table 4 Toxicity n (%)
| Unresectable(n = 55) | Recurrent(n = 10) | |||
| All grades | Grade 3-4 | All grades | Grade 3-4 | |
| Hematological | ||||
| Leukopenia | 33 (60) | 16 (29) | 9 (90) | 2 (20) |
| Neutropenia | 30 (55) | 16 (29) | 9 (90) | 6 (60) |
| Anemia | 41 (75) | 9 (16) | 7 (70) | 1 (10) |
| Thrombocytopenia | 25 (45) | 9 (16) | 5 (50) | 0 |
| Non-hematological | ||||
| Nausea | 12 (22) | 1 (2) | 4 (40) | 0 |
| Vomiting | 3 (5) | 0 | 2 (20) | 0 |
| Anorexia | 19 (35) | 2 (4) | 4 (40) | 0 |
| Stomatitis | 14 (25) | 0 | 2 (20) | 0 |
| Diarrhea | 7 (13) | 0 | 0 | 0 |
| Constipation | 16 (29) | 0 | 1 (10) | 0 |
| Pigmentation | 12 (22) | 0 | 3 (30) | 0 |
| Skin rash | 10 (18) | 3 (5) | 2 (20) | 0 |
| Liver dysfunction | 7 (13) | 1 (2) | 0 | 0 |
- Citation: Sasaki T, Isayama H, Nakai Y, Ito Y, Yasuda I, Toda N, Yagioka H, Matsubara S, Hanada K, Maguchi H, Kamada H, Hasebe O, Mukai T, Okabe Y, Maetani I, Koike K. Treatment outcomes of chemotherapy between unresectable and recurrent biliary tract cancer. World J Gastroenterol 2014; 20(48): 18452-18457
- URL: https://www.wjgnet.com/1007-9327/full/v20/i48/18452.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i48.18452